Centiva Capital, LP Alnylam Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 1,500 shares of ALNY stock, worth $360,825. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,500

Previous 1,000 50.0%

Holding current value

$360,825

Previous $243,000 69.55%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $223,989 - $274,955	-958 Reduced 95.8%	42 $11,000
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $143,310 - $247,000	1,000 New	1,000 $243,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $71,894 - $89,104	421 New	421 $74,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $63,174 - $105,792	456 New	456 $91,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $434,234 - $610,459	3,606 Added 139.01%	6,200 $904,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $329,904 - $451,122	2,594 New	2,594 $424,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $276,198 - $362,280	-1,731 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $499,913 - $611,764	-2,945 Reduced 62.98%	1,731 $327,000
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $601,473 - $827,137	4,676 New	4,676 $793,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $418,031 - $579,074	-3,296 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $11,559 - $13,818	94 Added 2.94%	3,296 $428,000
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $60,473 - $82,579	499 Added 18.46%	3,202 $466,000
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $223,113 - $334,938	2,141 Added 380.96%	2,703 $400,000
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $28,494 - $41,000	306 Added 119.53%	562 $61,000
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $87,102 - $145,224	-1,169 Reduced 82.04%	256 $29,000
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $101,032 - $125,143	1,425 New	1,425 $115,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Alnylam Pharmaceuticals, Inc. Transaction History